Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA, reshared the post by Yakup Ergün, Medical Oncologist at Antalya City Hospital, on X, adding:
“I trust the day is coming when all MEDICAL ONCOLOGISTS will stand up and say enough is enough for TACE.”
Quoting Yakup Ergün‘s post:
“Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC.
Pooled analysis of 3 RCTs.
Compared with TACE, EBRT yields superior local control and PFS early and intermediate stage HCC.”
Meta-analysis of randomized controlled trials of external-beam radiation versus transarterial chemoembolization for hepatocellular carcinoma.
Authors: Ryan A. Kuehnle BS, et al.
